Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aspire Biopharma Holdings ( (ASBP) ) has issued an announcement.
On April 16, 2026, Aspire Biopharma announced it had signed a letter of intent to acquire Dura Driver Control Systems, a tier-one global automotive supplier specializing in vehicle electrification, safety and human–machine interface systems, in an all-cash transaction valued at $30 million. The deal, which remains subject to due diligence, including a U.S. GAAP audit, would add a business that generated over $200 million in 2025 revenue and more than $22 million in Adjusted EBITDA, operates 11 facilities across North America, Europe and Asia, and serves major OEMs with a deep patented product portfolio.
If completed, the acquisition would mark a transformative diversification for Aspire from pure-play biopharma into a higher-revenue industrial and automotive technology platform, supported by DCS’s long-standing blue-chip customer relationships and consistent cash generation. Management of DCS would be strengthened by a team from Lakewood & Company bringing more than a century of collective automotive experience, while RBW Capital Partners advises Aspire on the deal, underscoring the company’s bid to reposition its growth profile and risk mix despite execution and integration uncertainties highlighted in the announcement.
More about Aspire Biopharma Holdings
Aspire Biopharma Holdings, Inc., based in Estero, Fla., is a biopharmaceutical company developing a patent-pending sublingual drug delivery technology designed to deliver active ingredients rapidly and precisely into the bloodstream while bypassing the gastrointestinal tract. Its platform can be applied across a broad range of small and large molecule therapeutics, as well as nutraceuticals and supplements, positioning the firm as a specialized drug delivery innovator within the life sciences sector.
Average Trading Volume: 832,792
Technical Sentiment Signal: Sell
Current Market Cap: $2.74M
See more insights into ASBP stock on TipRanks’ Stock Analysis page.